Therapy monitoring with FDG-PET in patients with metastatic colorectal cancer receiving FOLFOX chemotherapy.

被引：0
|
作者：
Dimitrakopoulou-Strauss, A
Rudi, J
Strauss, LG
机构：
[1] Univ Heidelberg, Med Clin, Heidelberg, Germany
[2] German Canc Res Ctr, D-6900 Heidelberg, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2000年 / 41卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
446
引用
收藏
页码：113P / 113P
页数：1
相关论文
共 50 条
  • [21] Survival of metastatic metaplastic breast cancer patients receiving chemotherapy.
    Kukunoor, Sparsha
    Lee, Anna
    Taiwo, Evelyn Oluwatoyin
    Schreiber, David
    Luhrs, Carol A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] FDG-PET scan in colorectal cancer
    Dane, Faysal
    Dede, Fuat
    Atasoy, Beste M.
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2008, 18 (02): : 121 - 128
  • [23] Chemotherapy efficacy in metastatic colorectal cancer (mCRC) patients treated with adjuvant or first-line FOLFOX-based chemotherapy.
    Samalin, Emmanuelle
    Tien Tuan Nguyen
    Thezenas, Simon
    Portales, Fabienne
    Mazard, Thibault
    Gourgou, Sophie
    Assenat, Eric
    Ychou, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [24] Early prediction of therapy-response using FDG-PET in patients with advanced melanoma treated with individualized chemotherapy.
    Kreissl, M. C.
    Dueren, C.
    Frey, L.
    Lorenz, R.
    Reiners, C.
    Ugurel, S.
    Becker, J. C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S217 - S217
  • [25] FDG-PET imaging in detecting recurrent or metastatic colorectal cancer in patients with elevated CEA levels
    Ponzo, F
    Zhuang, HM
    Lacorte, LB
    Alavi, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1017 - 1017
  • [26] Monitoring primary breast cancer throughout chemotherapy using FDG-PET
    McDermott, Garry M.
    Welch, Andrew
    Staff, Roger T.
    Gilbert, Fiona J.
    Schweiger, Lutz
    Semple, Scott I. K.
    Smith, Tim A. D.
    Hutcheon, Andrew W.
    Miller, Iain D.
    Smith, Ian C.
    Heys, Steven D.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 102 (01) : 75 - 84
  • [27] Monitoring primary breast cancer throughout chemotherapy using FDG-PET
    Garry M. McDermott
    Andrew Welch
    Roger T. Staff
    Fiona J. Gilbert
    Lutz Schweiger
    Scott I. K. Semple
    Tim A. D. Smith
    Andrew W. Hutcheon
    Iain D. Miller
    Ian C. Smith
    Steven D. Heys
    Breast Cancer Research and Treatment, 2007, 102 : 75 - 84
  • [28] Amifostine pretreatment for patients with advanced colorectal cancer receiving folfox chemotherapy
    Arena, F.
    Kurzyna-Solinas, A.
    Stark, R. F.
    Ohri, A.
    Schiffer, C.
    Sulzbach, H.
    Jemison, D.
    Dolat, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] The effect of oral β-glucan on mucositis and leukopenia in colorectal cancer patients receiving adjuvant FOLFOX-4 combination chemotherapy.
    Karaca, Halit
    Berk, Veli
    Inanc, Mevlude
    Dikilitas, Mustafa
    Ozkan, Metin
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] Impact of FDG-PET on management of patients with colorectal cancer.
    Meta, J
    Valk, P
    Ariannejad, M
    Seltzer, MA
    Wong, C
    Phelps, ME
    Gambhir, SS
    Czernin, J
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 299P - 299P
12345